3,480 reports of this reaction
5.5% of all NICOTINE POLACRILEX reports
#3 most reported adverse reaction
INTENTIONAL DRUG MISUSE is the #3 most commonly reported adverse reaction for NICOTINE POLACRILEX, manufactured by Haleon US Holdings LLC. There are 3,480 FDA adverse event reports linking NICOTINE POLACRILEX to INTENTIONAL DRUG MISUSE. This represents approximately 5.5% of all 62,946 adverse event reports for this drug.
NICOTINE POLACRILEX has an overall safety score of 78 out of 100. Patients taking NICOTINE POLACRILEX who experience intentional drug misuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
INTENTIONAL DRUG MISUSE is moderately reported among NICOTINE POLACRILEX users, representing a notable but not dominant share of adverse events.
In addition to intentional drug misuse, the following adverse reactions have been reported for NICOTINE POLACRILEX:
The following drugs have also been linked to intentional drug misuse in FDA adverse event reports:
INTENTIONAL DRUG MISUSE has been reported as an adverse event in 3,480 FDA reports for NICOTINE POLACRILEX. This does not prove causation, but indicates an association observed in post-market surveillance data.
INTENTIONAL DRUG MISUSE accounts for approximately 5.5% of all adverse event reports for NICOTINE POLACRILEX, making it one of the most commonly reported side effect.
If you experience intentional drug misuse while taking NICOTINE POLACRILEX, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.